United States

Analyst Research

Report Title Price
Provider : Reuters Investment Profile
Provider : Thomson Reuters Stock Report
Provider : GlobalData
Provider : MarketLine

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Daiichi Sankyo Co Ltd to establish subsidiary and to sell subsidiary to Alfresa Pharma

Thursday, 31 Jul 2014 03:30am EDT 

Daiichi Sankyo Co Ltd:To establish new subsidiary in September to succeed Akita plant, which is currently owned by subsidiary DAIICHI SANKYO PROPHARMA.To sell the new subsidiary named TBC to Alfresa Pharma on April 1, 2015.